HVEM Antikörper (AA 41-209)
TNFRSF14
Reaktivität: Human
WB, IHC, IP, IF/ICC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN2904406
-
-
Target
Alle HVEM (TNFRSF14) Antikörper anzeigen
-
HVEM (TNFRSF14)
(Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14))
-
Bindungsspezifität
-
AA 41-209
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser HVEM Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
-
Aufreinigung
-
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Immunogen
-
TNFRSF14 (Ser41-Ser209)
-
Top Product
-
Discover our top product TNFRSF14 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
500 μg/mL
-
Buffer
-
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
4 °C,-20 °C
-
Informationen zur Lagerung
-
Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
-
Target
-
HVEM (TNFRSF14)
(Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14))
-
Andere Bezeichnung
-
Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14 Produkte)
-
Synonyme
-
ATAR antikoerper, CD270 antikoerper, HVEA antikoerper, HVEM antikoerper, LIGHTR antikoerper, TR2 antikoerper, Atar antikoerper, HveA antikoerper, Hvem antikoerper, Tnfrs14 antikoerper, TNF receptor superfamily member 14 antikoerper, tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) antikoerper, Tnfrsf14 antikoerper, TNFRSF14 antikoerper
-
Substanzklasse
-
Viral Protein
-
Pathways
-
Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-